| |
 |
|
|
|
|
|
Poster: 49
Visits: 144
Title: What we learn from data of a prospective post-authorization safety surveillance study in 384 hemophilia A patients with antihemophilic factor (recombinant) plasma / albumin free method demonstrates safety and efficacy in Japan
Authors: KATSUYUKI FUKUTAKE , Hideji Hanabusa, Masashi Taki, Tadashi Matsushita, Keiji Nogami, Akira Shirahata, Mutsumi Shiraishi and ADVATE J-PASS Study group
Centre: Tokyo Medical University
|
|
You must be registered to reply or comment.
|
|
WHAT WE LEARN FROM DATA OF A PROSPECTIVE POST-AUTHORIZATION SAFETY SURVEILLANCE STUDY IN 384 HEMOPHILIA A PATIENTS WITH ANTIHEMOPHILIC FACTOR (RECOMBINANT) PLASMA / ALBUMIN FREE METHOD DEMONSTRATES SAFETY AND EFFICACY IN JAPAN
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 43
Visits: 280
Title: A Clinical Study In Previously Untreated Patients With Severe Haemophilia A - Immunogenicity, Efficacy and Safety Of Treatment With Human-cl rhFVIII
Authors: Raina Liesner , M Jansen, S Knaub
Centre: Octapharma Clinical R&D
|
|
|
|
